Inventors and their attorneys must beware of their actions before the US Patent and Trademark Office

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.4, 2004-04, pp. : 453-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inventors and their attorneys must beware of their actions before the US Patent & Trademark Office

By Warburg Richard Nguyen Lauren

Pharmacogenomics, Vol. 5, Iss. 2, 2004-03 ,pp. : 143-147

Future Medicine

Access to resources Recommend Favorite

Tissue engineering: a historical review as seen through the US Patent Office

By Pabst Patrea L

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. : 347-352

Informa Healthcare

Access to resources Recommend Favorite

Patent prosecution at the European Patent Office: what is new for life sciences applicants?

By Lidéén Camilla Setrééus Ellen

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 813-817

Informa Healthcare

Access to resources Recommend Favorite

Primary care must be addressed by US presidential hopefuls

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 547, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Primary care must be addressed by US presidential hopefuls

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite